These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 27029036)
1. Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms. Bartels S; Schipper E; Hasemeier B; Kreipe H; Lehmann U Oncotarget; 2016 May; 7(21):30084-93. PubMed ID: 27029036 [TBL] [Abstract][Full Text] [Related]
2. The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm. Ibrar W; Zhang W; Cox JL; Cushman-Vokoun A; Fu K; Greiner TC; Yuan J Int J Lab Hematol; 2021 Dec; 43(6):1501-1509. PubMed ID: 34270867 [TBL] [Abstract][Full Text] [Related]
3. Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study. Fei F; Jariwala A; Pullarkat S; Loo E; Liu Y; Tizro P; Ali H; Otoukesh S; Amanam I; Artz A; Ally F; Telatar M; Nakamura R; Marcucci G; Afkhami M Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337700 [TBL] [Abstract][Full Text] [Related]
4. Genetic landscape of recurrent ASXL1, U2AF1, SF3B1, SRSF2, and EZH2 mutations in 304 Chinese patients with myelodysplastic syndromes. Wu L; Song L; Xu L; Chang C; Xu F; Wu D; He Q; Su J; Zhou L; Xiao C; Zhang Z; Zhao Y; Chen S; Li X Tumour Biol; 2016 Apr; 37(4):4633-40. PubMed ID: 26508027 [TBL] [Abstract][Full Text] [Related]
5. Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2 Todisco G; Creignou M; Gallì A; Guglielmelli P; Rumi E; Roncador M; Rizzo E; Nannya Y; Pietra D; Elena C; Bono E; Molteni E; Rosti V; Catricalá S; Sarchi M; Dimitriou M; Ungerstedt J; Vannucchi AM; Hellström-Lindberg E; Ogawa S; Cazzola M; Malcovati L Leukemia; 2021 Aug; 35(8):2371-2381. PubMed ID: 33349666 [TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML. Schuler E; Frank F; Hildebrandt B; Betz B; Strupp C; Rudelius M; Aul C; Schroeder T; Gattermann N; Haas R; Germing U Leuk Res; 2018 Feb; 65():1-4. PubMed ID: 29216536 [TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors. Je EM; Yoo NJ; Kim YJ; Kim MS; Lee SH Int J Cancer; 2013 Jul; 133(1):260-5. PubMed ID: 23280334 [TBL] [Abstract][Full Text] [Related]
8. SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Meggendorfer M; Bacher U; Alpermann T; Haferlach C; Kern W; Gambacorti-Passerini C; Haferlach T; Schnittger S Leukemia; 2013 Sep; 27(9):1852-60. PubMed ID: 23628959 [TBL] [Abstract][Full Text] [Related]
10. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia. Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934 [TBL] [Abstract][Full Text] [Related]
11. [Diagnostic molecular pathology of lymphatic and myeloid neoplasms]. Klapper W; Kreipe H Pathologe; 2015 Mar; 36(2):164-70. PubMed ID: 25809654 [TBL] [Abstract][Full Text] [Related]
12. Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS. Kanagal-Shamanna R; Luthra R; Yin CC; Patel KP; Takahashi K; Lu X; Lee J; Zhao C; Stingo F; Zuo Z; Routbort MJ; Singh RR; Fox P; Ravandi F; Garcia-Manero G; Medeiros LJ; Bueso-Ramos CE Oncotarget; 2016 Mar; 7(12):14251-8. PubMed ID: 26883102 [TBL] [Abstract][Full Text] [Related]
13. Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia. Malcovati L; Papaemmanuil E; Ambaglio I; Elena C; Gallì A; Della Porta MG; Travaglino E; Pietra D; Pascutto C; Ubezio M; Bono E; Da Vià MC; Brisci A; Bruno F; Cremonesi L; Ferrari M; Boveri E; Invernizzi R; Campbell PJ; Cazzola M Blood; 2014 Aug; 124(9):1513-21. PubMed ID: 24970933 [TBL] [Abstract][Full Text] [Related]
14. Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Wang SA; Hasserjian RP; Fox PS; Rogers HJ; Geyer JT; Chabot-Richards D; Weinzierl E; Hatem J; Jaso J; Kanagal-Shamanna R; Stingo FC; Patel KP; Mehrotra M; Bueso-Ramos C; Young KH; Dinardo CD; Verstovsek S; Tiu RV; Bagg A; Hsi ED; Arber DA; Foucar K; Luthra R; Orazi A Blood; 2014 Apr; 123(17):2645-51. PubMed ID: 24627528 [TBL] [Abstract][Full Text] [Related]
15. Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Thol F; Kade S; Schlarmann C; Löffeld P; Morgan M; Krauter J; Wlodarski MW; Kölking B; Wichmann M; Görlich K; Göhring G; Bug G; Ottmann O; Niemeyer CM; Hofmann WK; Schlegelberger B; Ganser A; Heuser M Blood; 2012 Apr; 119(15):3578-84. PubMed ID: 22389253 [TBL] [Abstract][Full Text] [Related]
16. Pathogenic Mutations and Atypical Flow Cytometric Findings Characterize the Majority of Unclassifiable Myelodysplastic/Myeloproliferative Neoplasms. Li Y; Beck RC; Moore EM Am J Clin Pathol; 2021 Sep; 156(4):634-643. PubMed ID: 33877292 [TBL] [Abstract][Full Text] [Related]
17. Mutations in idiopathic cytopenia of undetermined significance assist diagnostics and correlate to dysplastic changes. Hansen JW; Westman MK; Sjö LD; Saft L; Kristensen LS; Ørskov AD; Treppendahl M; Andersen MK; Grønbaek K Am J Hematol; 2016 Dec; 91(12):1234-1238. PubMed ID: 27717004 [TBL] [Abstract][Full Text] [Related]
18. Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia. Hou HA; Liu CY; Kuo YY; Chou WC; Tsai CH; Lin CC; Lin LI; Tseng MH; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Li CC; Huang SY; Ko BS; Hsu SC; Chen CY; Lin CT; Wu SJ; Tsay W; Tien HF Oncotarget; 2016 Feb; 7(8):9084-101. PubMed ID: 26812887 [TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of DTA mutation and co-occurring mutations in patients with myelodysplastic syndrome. Wang M; Chen P; Li D; Zhao M Mol Biol Rep; 2024 Sep; 51(1):985. PubMed ID: 39278886 [TBL] [Abstract][Full Text] [Related]
20. Clinical Evaluation of a Novel Nine-Gene Panel for Ion Torrent PGM Sequencing of Myeloid Malignancies. Ivanova M; Shivarov V; Pavlov I; Lilakos K; Naumova E Mol Diagn Ther; 2016 Feb; 20(1):27-32. PubMed ID: 26476543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]